BCM
TLSIW icon

Basso Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Basso Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,468
Closed -$3K – 100
2022
Q3 		$3K Hold
52,468
– – ﹤0.01% 359
2022
Q2 		$4K Hold
52,468
– – ﹤0.01% 564
2022
Q1 		$13K Buy
+52,468
New +$22.6K ﹤0.01% 592

Other funds holding TLSIW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Basso Capital Management's TLSIW Position: Q4 2022 in Review

Basso Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2022, closing a stake of 52,468 shares — an estimated $3K sold.

Basso Capital Management first reported a position in TLSIW in Q1 2022 and held it in 3 quarters. The position peaked at $13K in Q1 2022. 29 funds tracked by Wall St. Rank hold TLSIW as of Q4 2022.

  • Basso Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2022 after selling out during the quarter.
  • Basso Capital Management sold 52,468 TriSalus Life Sciences Warrant shares in Q4 2022, an estimated $3K.
  • Basso Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2022 and held it in 3 quarters.
  • Basso Capital Management's TriSalus Life Sciences Warrant position peaked at $13K in Q1 2022.
  • 29 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2022.

Based on Basso Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.